> the Journal also started letting people read for free links that are shared on social media by subscribers and staffers.
Because the publisher explicitly allows it.
Because the publisher explicitly allows it.
It's really simple, if you want to put your content behind a paywall, then put it behind a paywall. Don't leave a backdoor open and then complain when people use that door.
By definition sharing means giving it away for free.
Etc, etc. But again, I know there are holes in my reasoning.
That'd have to be an incredibly large one-time payment. And how would we know how much to pay?
It doesn't seem like an unsolvable problem. The drug companies themselves must have budgets, and the publicly traded ones have a stock price. So someone somewhere must be able to create estimates for this.